Brokerages Set Astrana Health, Inc. (NASDAQ:ASTH) Target Price at $65.17

Astrana Health, Inc. (NASDAQ:ASTH) has earned a consensus rating of “Moderate Buy” from the nine analysts that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $63.67.

Several equities analysts have recently commented on ASTH shares. TD Cowen started coverage on Astrana Health in a research note on Monday, October 14th. They issued a “buy” rating and a $66.00 price target on the stock. Macquarie raised Astrana Health to a “hold” rating in a research note on Monday, December 16th. Robert W. Baird increased their target price on Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. BTIG Research upped their price target on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a report on Thursday, October 3rd. Finally, Truist Financial cut their price target on Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a report on Monday.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. GAMMA Investing LLC purchased a new position in shares of Astrana Health in the 3rd quarter valued at about $34,000. Nisa Investment Advisors LLC purchased a new position in shares of Astrana Health in the 3rd quarter valued at about $35,000. KBC Group NV purchased a new position in shares of Astrana Health in the 3rd quarter valued at about $70,000. Quarry LP purchased a new position in shares of Astrana Health in the 3rd quarter valued at about $77,000. Finally, Quest Partners LLC purchased a new position in shares of Astrana Health in the 3rd quarter valued at about $133,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Stock Performance

NASDAQ ASTH opened at $30.28 on Friday. The stock’s fifty day moving average is $39.55 and its two-hundred day moving average is $47.05. The firm has a market capitalization of $1.70 billion, a P/E ratio of 23.29, a price-to-earnings-growth ratio of 1.80 and a beta of 1.20. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. Astrana Health has a fifty-two week low of $29.08 and a fifty-two week high of $63.20.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.33. The company had revenue of $478.71 million for the quarter, compared to analyst estimates of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same quarter in the previous year, the company posted $0.47 earnings per share. On average, research analysts anticipate that Astrana Health will post 1.16 earnings per share for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.